Japan PMDA New Drug Approval Watch
Pricing
from $134.00 / 1,000 drug approval deltas
Japan PMDA New Drug Approval Watch
Japanese new-drug approvals as PMDA records them: approval date, brand name, marketing-authorisation holder with its corporate number, active ingredient,…
Pricing
from $134.00 / 1,000 drug approval deltas
Rating
0.0
(0)
Developer
NexGen Watch
Maintained by CommunityActor stats
0
Bookmarked
2
Total users
1
Monthly active users
14 days ago
Last modified
Share
Japanese new-drug approvals as PMDA records them: approval date, brand name, marketing-authorisation holder with its corporate number, active ingredient, approval kind (new approval vs partial change) and the approved indication. Read from PMDA's own fiscal-year approval workbook, so a delta means a drug was approved — not that a document was regenerated.
Source
PMDA fiscal-year new-drug approval list, 承認品目一覧（新医薬品）(public, logged-out)
Public, logged-out only — no API key, login, cookie or CAPTCHA.
Pricing
| Event | Price (FREE tier) |
|---|---|
Actor start (apify-actor-start) | $0.02 one-time |
Source check (source-check) | $0.10 |
Per delta (drug-approval-delta) | $0.20 |
source-check ladder, GOLD-floored: $0.10 / $0.09 / $0.08 / $0.067.
Charged once per run after the source enumeration terminates — seed runs and
genuine-zero runs included. It is not charged when the source refused the
read: a run that never read the source has not performed a source check.
The per-delta value event (drug-approval-delta) is the primary event and is priced at
$0.20 per delta at the FREE tier. Ladder, GOLD-floored:
$0.20 / $0.18 / $0.16 / $0.134 (FREE / BRONZE / SILVER / GOLD-PLATINUM-DIAMOND).
source-check still charges; it is no longer the headline event. Billed deltas
are capped at 500 per run and any overflow is reported as a withholding rather
than charged.
Snapshot mode is a PREVIEW
watch_mode: false returns at most 25 records, hard-capped in code
regardless of any input, labeled output_mode: "preview". This actor sells
change detection, not bulk record export.
Watch semantics
The first watch run stores a private baseline and emits zero deltas. Later
runs emit NEW / CHANGED / REMOVED keyed on the source-native id with
before / after and changed_fields. Billed deltas are capped at 500 per
run; the overflow is reported as a named PARTIAL withholding, is never billed,
and is re-detected on the next run.
Terminal states
NORMAL · SUCCEEDED-0: GENUINE_EMPTY · SUCCEEDED-0 (no change) · PARTIAL · BLOCKED.
A zero with no evidence FAILS loud rather than exiting 0 quietly.
Approvals arrive in batches, not on a daily drip
PMDA approves new drugs in rounds and republishes its fiscal-year workbook in batches, so this feed is lumpy by construction. Measured on 2026-07-27: 38 approvals across a 39-day span in the FY2026 workbook, about 6.8 a week — but 0 in the trailing 30 days, newest approval dated 2026-06-19.
That is the source behaving normally, not this Actor failing. Expect long quiet stretches and
then several deltas in a single run. Read a SUCCEEDED-0 (no change) as "the workbook has not
been republished since the last read", not as "no drugs were approved" — and budget against
the batch rather than against a daily average.
